α-Bromotoluene-d7 is a deuterium-labeled compound used as a pharmaceutical synthetic intermediate; it can be employed in the preparation of 2,5-dimethyl-6-(4-((phenyl-d5)methoxy-d2)piperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one, which exhibits antiparasitic activity against kinetoplastid protozoa by inhibiting parasitic proteasomes and suppressing the growth of kinetoplastid parasites; it has therapeutic potential for the treatment of leishmaniasis and Chagas disease.